TransMedics

Q2 FY2026 EarningsQ2 FY26 beat revenue consensus but missed on the bottom line due to aggressive strategic investments. Revenue was $189.9M vs. $184.0M expected (+3.2% variance), driven by a 29% surge in Service revenue. However, Adjusted EPS of $0.44 missed the $0.48 consensus by 8.3%, and GAAP Net Income of $14.7M fell short of the $18.1M forecast. Management raised the low end of FY26 revenue guidance to $737M-$757M, reinforcing a growth-first strategy as the company invests in European air logistics through the PAD Aviation acquisition.